Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 4
2008 1
2009 2
2010 1
2012 1
2013 1
2014 3
2017 1
2019 1
2020 3
2021 1
2022 7
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.
Fong Y, McDermott AB, Benkeser D, Roels S, Stieh DJ, Vandebosch A, Le Gars M, Van Roey GA, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Hyrien O, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Kenny A, Carone M, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Little SJ, Paiva de Sousa L, Maboa R, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Carpp LN, Follmann D, Gilbert PB, Koup RA, Donis RO; Immune Assays Team; the Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; and the United States Government (USG)/CoVPN Biostatistics Team. Fong Y, et al. Among authors: wolfe dn. Nat Microbiol. 2022 Dec;7(12):1996-2010. doi: 10.1038/s41564-022-01262-1. Epub 2022 Nov 10. Nat Microbiol. 2022. PMID: 36357712 Free PMC article. Clinical Trial.
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report.
Knisely JM, Buyon LE, Mandt R, Farkas R, Balasingam S, Bok K, Buchholz UJ, D'Souza MP, Gordon JL, King DFL, Le TT, Leitner WW, Seder RA, Togias A, Tollefsen S, Vaughn DW, Wolfe DN, Taylor KL, Fauci AS. Knisely JM, et al. Among authors: wolfe dn. NPJ Vaccines. 2023 Apr 12;8(1):53. doi: 10.1038/s41541-023-00654-6. NPJ Vaccines. 2023. PMID: 37045860 Free PMC article.
Selection of Filovirus Isolates for Vaccine Development Programs.
Wolfe DN, Sabourin CL, Merchlinsky MJ, Florence WC, Wolfraim LA, Taylor KL, Ward LA. Wolfe DN, et al. Vaccines (Basel). 2021 Sep 19;9(9):1045. doi: 10.3390/vaccines9091045. Vaccines (Basel). 2021. PMID: 34579282 Free PMC article.
Natural History of Sudan ebolavirus to Support Medical Countermeasure Development.
Carbonnelle C, Moroso M, Pannetier D, Godard S, Mély S, Thomas D, Duthey A, Jourjon O, Lacroix O, Labrosse B, Raoul H, Osman KL, Salguero FJ, Hall Y, Sabourin CL, Merchlinsky MJ, Long JP, Parish LA, Wolfe DN. Carbonnelle C, et al. Among authors: wolfe dn. Vaccines (Basel). 2022 Jun 16;10(6):963. doi: 10.3390/vaccines10060963. Vaccines (Basel). 2022. PMID: 35746571 Free PMC article.
Current biodefense vaccine programs and challenges.
Wolfe DN, Florence W, Bryant P. Wolfe DN, et al. Hum Vaccin Immunother. 2013 Jul;9(7):1591-7. doi: 10.4161/hv.24063. Epub 2013 Feb 21. Hum Vaccin Immunother. 2013. PMID: 23428906
28 results